ArticleHealth science reports2026
Correlation Between Coagulopathy and Glycemic Control Among People With Type 2 Diabetes Mellitus in the Southwestern Cameroon, a Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Hemostatic complications are the leading cause of mortality among people with type 2 diabetes mellitus (T2DM). Studies on hemostatic parameters of people with T2DM have shown different results. This study investigated coagulation profiles of people with T2DM, and its association with glycemic control. Methods: A hospital-based cross-sectional study was conducted among 160 people with T2DM at the Buea and Limbe Regional Hospitals from January 2024 to May 2024. Prothrombin time (PT), activated partial thromboplastin time (APTT), protein C, d-dimer, fibrinogen and platelets were estimated. Fasting plasma glucose was measured by an enzymatic colorimetric method, and glycated hemoglobin using an ion exchange resin method. Data were analyzed using SPSS. Significance was set at Results: The prevalence of coagulopathy in this study was 24.4%, with a higher prevalence in patients with poor glycemic control (32.4%). Being a female ([ Conclusion: Coagulopathy is more common in people with T2DM with poor glycemic control. Female gender, old age, longer duration of diabetes, and obesity contribute to coagulopathy in patients with T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.